FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi

Go back to FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.54 -1.35 (2.71%)
Previous Close $49.89    52 Week High $45.58 
Open $49.00    52 Week Low $37.82 
Day High $49.23    P/E N/A 
Day Low $48.54    EPS $0.00 
Volume 3,062,278       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.19 -0.02 (1.65%)
Previous Close $1.21    52 Week High $3.85 
Open $1.21    52 Week Low $1.25 
Day High $1.22    P/E N/A 
Day Low $1.19    EPS $-0.28 
Volume 348,593